Sovereign Pharmaceuticals, LLC

Form 483 issued April 22, 2022 · Fort Worth, Texas

Inspection
Apr 13 – Apr 22, 2022
Investigator
Adaris Mas Rivera
Observations
4
Pages
6
FEI number
3003229412

In short: On April 22, 2022, FDA issued a Form 483 with 4 observations to Sovereign Pharmaceuticals, LLC in Fort Worth, Texas (FEI 3003229412) after an inspection that ran Apr 13 – Apr 22, 2022. The investigator was Adaris Mas Rivera. Most observations concern quality system and production.

At a glance

Quality system and production account for 3 of 4 observations.

Quality system2
Production1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Written procedures are not drafted, reviewed and approved by…

  2. 02

    The responsibilities and procedures applicable to the quality control unit…

  3. 03

    Procedures describing the handling of all written and oral complaints regarding a drug…

  4. 04

    Laboratory controls do not include the establishment of scientifically sound and appropriate sampling plans designed to…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sovereign Pharmaceuticals, LLC?

FDA listed 4 observations on this Form 483, mostly about quality system, production and laboratory controls. The opening words of each observation are shown on this page.

Who inspected Sovereign Pharmaceuticals, LLC?

Adaris Mas Rivera is named on this Form 483, for the inspection of Apr 13 – Apr 22, 2022. Each investigator has a profile showing what they cite most.

When was Sovereign Pharmaceuticals, LLC inspected by FDA?

The inspection ran Apr 13 – Apr 22, 2022, and the Form 483 is dated April 22, 2022.

How do I get the full Form 483 for Sovereign Pharmaceuticals, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free